PRIME MEMBER EXCLUSIVE | 3 Months Free Trial
Auto-renews at INR 199/mo after 3 months. Cancel anytime. Offer ends 15 July, 2026.
Marc Gitzinger, BioVersys
Failed to add items
Add to cart failed.
Add to wishlist failed.
Remove from wishlist failed.
Follow podcast failed
Unfollow podcast failed
-
Narrated by:
-
Written by:
Why is self-awareness the secret ingredient to good leadership?
How do you let go of a critical early team member?
And what does it take to found a company during your PhD?
Today I’m joined by Marc Gitzinger, CEO of BioVersys, a biotech based in Basel, Switzerland. BioVersys is a leader in the anti-infective space, developing new antibiotics for very highly drug-resistant infections.
About LifeScience ORG
It’s no secret that Europe is a global leader in generating translational science. We’re grateful at LifeScience ORG to have a community of over 400 life science CEOs – leaders driving change in biotech, medtech, techBio and healthcare.
The conversations inside our community – stories of conviction, navigating challenges, and making bold decisions – inspire us every week. To hear the stories, lessons, and experiences of our life science leaders, listen to A Call to Lead @ LifeScience ORG, available on all good podcasting platforms.
Chapters
01:16 — From the Lab to the Boardroom
02:51 — The Naivety That Gets You Started
04:08 — When the Board Asks the Impossible
09:12 — Managing Up: Working With Your Board
11:42 — Try Before You Buy: Choosing Independent Directors
15:25 — Three Experts, One Decision
17:05 — A Culture of Calculated Risk
19:05 — A Hub Unlike Any Other
20:40 — The Antibiotic Paradox
25:14 — Stigma, Silence, and Resistant Infections
35:15 — The Mirror Test